Alnylam Pharmaceuticals Appoints Pushkal Garg as Chief Research and Development Officer
Position
Chief Development Officer
Company
Alnylam Pharmaceuticals
CambridgeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Alnylam Pharmaceuticals has announced the appointment of Pushkal Garg, M.D., as their Executive Vice President and Chief Research and Development Officer. He will oversee an integrated R&D organization, leveraging his strategic vision and operational excellence.
Quick answer
Alnylam Pharmaceuticals Appoints Pushkal Garg as Chief Research and Development Officer (June 19, 2025). Alnylam Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Development Officer at Alnylam Pharmaceuticals?
- Alnylam Pharmaceuticals named Pushkal Garg Chief Development Officer, announced June 19, 2025.
- What did Alnylam Pharmaceuticals announce on June 19, 2025?
- Alnylam Pharmaceuticals has announced the appointment of Pushkal Garg, M.D., as their Executive Vice President and Chief Research and Development Officer. He will oversee an integrated R&D organization, leveraging his strategic vision and operational excellence.
- What does Alnylam Pharmaceuticals do?
- Alnylam Pharmaceuticals, Inc. is a leading RNAi therapeutics company focused on developing novel medicines to treat genetically defined diseases.
- Where is Alnylam Pharmaceuticals based?
- Alnylam Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- OnCusp Therapeutics (June 23, 2025), ISOThrive (July 2, 2025), Jazz Pharmaceuticals plc (July 10, 2025) and Acadia Pharmaceuticals (May 27, 2025) also announced leadership changes within 45 days of Alnylam Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- OnCusp Therapeutics Appoints Dimitry S.A. Nuyten as Chief Medical Officer (June 23, 2025)
- ISOThrive Inc. Appoints Mike Walther as Chief Strategy Officer (July 2, 2025)
- Jazz Pharmaceuticals Appoints Renee Gala as Chief Executive Officer (July 10, 2025)
- Acadia Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President (May 27, 2025)
- CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer (July 21, 2025)
- Avadel Pharmaceuticals Appoints Susan Rodriguez as Chief Operating Officer (May 13, 2025)
Who to call at Alnylam Pharmaceuticals, and when
A new leader at Alnylam Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Alnylam Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alnylam Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alnylam Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alnylam Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alnylam Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.